Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3847765 | American Journal of Kidney Diseases | 2014 | 15 Pages |
Abstract
The KDIGO (Kidney Disease: Improving Global Outcomes) clinical practice guideline for management of glomerulonephritis was recently released. The Canadian Society of Nephrology convened a working group to review the recommendations and comment on their relevancy and applicability to the Canadian context. A subgroup of adult nephrologists reviewed the guideline statements for management of glomerular disease in adults and agreed with most of the guideline statements developed by KDIGO. This commentary highlights areas for which there is lack of evidence and areas in need of translation of evidence into clinical practice. Areas of controversy or uncertainty, including the choice of second-line agents, are discussed in more detail. Existing practice variation also is addressed. The relevance of treatment recommendations to the Canadian practitioner is discussed.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Andrey V. MD, FRCPC, Michael MD, FRCPC, Greg MD, FRCPC, Michelle MSc, MD, FRCPC, Joanne MD, FRCPC, Heather MD, FRCPC, Atul MD, FRCP, Susan MD, FRCPC, Martin MD, FRCPC, Michael MD, FRCPC, Allison MD, FRCPC, Cherry MD, FRCPC, Maury MD, FRCPC, Norman MD,